Browse deals
← Back to deals
● LiveAcquireAcquireOtherliver health, supplement brand

Clinically studied liver brand: $3.5M TTM, $1.29M/yr subs, $139 AOV, 81% margin, $431K adj. EBITDA

Clinically studied liver brand: $3.5M TTM, $1.29M/yr subs, $139 AOV, 81% margin, $431K adj. EBITDA is an Other business listed at $2,250,000 on Acquire, in liver health, supplement brand. It reports $196,692 of annual profit, a 11.40x multiple. Acquisiteur has tracked this listing since Nov 1, 2026 and its status is still live. Comparable Other businesses close at a median 2.69x annual profit.

First seen Nov 1, 2026 · last checked 22 hours ago

AcquireOpen at Acquire ↗
Asking price
$2,250,000
Annual profit
$196,692
Annual revenue
$3,542,459
Profit multiple
11.40x
Monthly profit
$16,391
Age
1 yr

Confidence in this listing

Enough to judge the shape of it, not enough to price it.

57/100

What is documented
  • Profit figure published
  • Net margin 6%
What to ask about
  • Listed through a marketplace, figures as supplied
  • A 11.4x multiple, outside what this market clears
  • First seen here in the last few days

This scores the paperwork, not the business. Acquire: listed through a marketplace, figures as supplied. Always verify the figures with the seller before making an offer.

Overview

This is a high-margin, subscription-first daily liver and metabolic health brand for adults who drink, selling a clinically studied supplement through Shopify and Amazon. The product is rated 4.8 stars across 773+ verified reviews, customers stay on multi-month subscriptions, and operations are fully outsourced. In 20 months the company generated $5.5M in gross sales ($4.8M net revenue through September), including $3.54M in the last 12 months, with 25,000+ customers across Shopify and Amazon. Adjusted EBITDA before management compensation was $431K for the 12 months to June 2026: $255.9K of EBITDA plus $174.6K of one-off projects, ended retainers and owner items, verified line by line in a general-ledger review. The platform's $196.7K net profit covers the year to September, a different period. ✅ $107K a month in subscription MRR across 2,659 active subscriptions (Loop $83.9K, Amazon Subscribe & Save $23.6K average); more than half of September revenue came from subscription renewals, and 6-month plans collect $239 upfront ✅ 49% of 6-month and 57% of 3-month subscribers renew for another term; subscribers are worth $339 each to date and still rising, and 2026 cohorts retain like 2025 ✅ Completed 12-week pre/post study of the finished formula, run by an independent research company: 92% woke refreshed more often, 94% improved on five or more of nine outcomes, 75% had a decrease in at least one liver enzyme ✅ Exclusive on-demand inventory agreement: avoids funding large production runs, with about $31K of stock on hand ✅ Exclusive rights to a patented ingredient, 1,000+ clinician recommendations, a first direct clinic order (October 2026) and an at-home liver blood test kit ✅ Built by founders with prior exits and advised by operators behind notable consumer-health and beverage-brand exits ✅ Growth upside: the new study claims in ads, retail and practitioner channels, Amazon, 11,500+ one-time buyers to convert, new SKUs and international expansion

Price & status history

  1. ListedNov 1, 2026

Get new Other businesses like this one, every morning

One email a day with what just listed across every marketplace, priced against real closed sales. Free, no card.

$

Only the new listings that match, every morning. Free, no card, unsubscribe in one click.

Similar live deals